Detalles de la búsqueda
1.
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20152322
2.
Heterologous vaccination with inactivated and mRNA vaccines increases B and T cell responses to SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22268755
3.
Human serum from SARS-CoV-2 vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant in comparison to the original Wuhan strain and the Beta and Delta variants
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267523
4.
SARS-CoV-2 vaccine breakthrough infections are asymptomatic or mildly symptomatic and are infrequently transmitted.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259500
5.
Immunity to SARS-CoV-2 up to 15 months after infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-463699
6.
Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-371617
7.
Bispecific antibody prevents SARS-CoV-2 escape and protects mice from disease
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-427567
8.
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-515932
Resultados
1 -
8
de 8
1
Próxima >
>>